APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stage 1 Infant Formula

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Stage 1 Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026190 pages

Choose your research edition.

Industry ResearchStage 1 Infant Formula Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Stage 1 Infant Formula Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Stage 1 Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stage 1 Infant Formula Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Stage 1 Infant Formula Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Stage 1 Infant Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Stage 1 Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Stage 1 Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Stage 1 Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Stage 1 Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Stage 1 Infant Formula include Mead Johnson, Nestle, Danone, Abbott, FrieslandCampina, Heinz, Bellamy, Topfer and HiPP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Stage 1 Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stage 1 Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stage 1 Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Stage 1 Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.

Stage 1 Infant Formula Segment by Company

Mead Johnson

Nestle

Danone

Abbott

FrieslandCampina

Heinz

Bellamy

Topfer

HiPP

Perrigo

Arla

Holle

Meiji

Biostime

China Feihe

Junlebao Dairy

Ausnutria Dairy

Yili Group

Synutra

Beingmate

Yashili

Bright Dairy

Stage 1 Infant Formula Segment by Type

Conventional

Organic

Stage 1 Infant Formula Segment by Application

Online Sales

Offline Sales

Stage 1 Infant Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stage 1 Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stage 1 Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stage 1 Infant Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Stage 1 Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Stage 1 Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Stage 1 Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Stage 1 Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Stage 1 Infant Formula Industry Trends Table 2. Stage 1 Infant Formula Industry Drivers Table 3. Stage 1 Infant Formula Industry Opportunities and Challenges Table 4. Stage 1 Infant Formula Industry Restraints Table 5. Global Stage 1 Infant Formula Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Stage 1 Infant Formula Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Stage 1 Infant Formula Sales by Manufacturers (t) & (2021-2026) Table 8. Global Stage 1 Infant Formula Sales Market Share by Manufacturers Table 9. Global Stage 1 Infant Formula Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Stage 1 Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Stage 1 Infant Formula Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Stage 1 Infant Formula Manufacturers, Product Type & Application Table 13. Global Stage 1 Infant Formula Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Stage 1 Infant Formula by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Conventional Table 17. Major Manufacturers of Organic Table 18. Global Stage 1 Infant Formula Sales by Type 2021 VS 2025 VS 2032 (t) Table 19. Global Stage 1 Infant Formula Sales by Type (2021-2026) & (t) Table 20. Global Stage 1 Infant Formula Sales by Type (2027-2032) & (t) Table 21. Global Stage 1 Infant Formula Sales Market Share by Type (2021-2026) Table 22. Global Stage 1 Infant Formula Sales Market Share by Type (2027-2032) Table 23. Global Stage 1 Infant Formula Revenue by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Stage 1 Infant Formula Revenue by Type (2021-2026) & (t) Table 25. Global Stage 1 Infant Formula Revenue by Type (2027-2032) & (t) Table 26. Global Stage 1 Infant Formula Revenue Market Share by Type (2021-2026) Table 27. Global Stage 1 Infant Formula Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Sales Table 29. Major Manufacturers of Offline Sales Table 30. Global Stage 1 Infant Formula Sales by Application 2021 VS 2025 VS 2032 (t) Table 31. Global Stage 1 Infant Formula Sales by Application (2021-2026) & (t) Table 32. Global Stage 1 Infant Formula Sales by Application (2027-2032) & (t) Table 33. Global Stage 1 Infant Formula Sales Market Share by Application (2021-2026) Table 34. Global Stage 1 Infant Formula Sales Market Share by Application (2027-2032) Table 35. Global Stage 1 Infant Formula Revenue by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Stage 1 Infant Formula Revenue by Application (2021-2026) & (t) Table 37. Global Stage 1 Infant Formula Revenue by Application (2027-2032) & (t) Table 38. Global Stage 1 Infant Formula Revenue Market Share by Application (2021-2026) Table 39. Global Stage 1 Infant Formula Revenue Market Share by Application (2027-2032) Table 40. Global Stage 1 Infant Formula Sales by Region: 2021 VS 2025 VS 2032 (t) Table 41. Global Stage 1 Infant Formula Sales by Region (2021-2026) & (t) Table 42. Global Stage 1 Infant Formula Sales Market Share by Region (2021-2026) Table 43. Global Stage 1 Infant Formula Sales Forecasted by Region (2027-2032) & (t) Table 44. Global Stage 1 Infant Formula Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 46. North America Stage 1 Infant Formula Sales by Country (2021-2026) & (t) Table 47. North America Stage 1 Infant Formula Sales by Country (2027-2032) & (t) Table 48. Europe Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 49. Europe Stage 1 Infant Formula Sales by Country (2021-2026) & (t) Table 50. Europe Stage 1 Infant Formula Sales by Country (2027-2032) & (t) Table 51. Asia Pacific Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 52. Asia Pacific Stage 1 Infant Formula Sales by Country (2021-2026) & (t) Table 53. Asia Pacific Stage 1 Infant Formula Sales by Country (2027-2032) & (t) Table 54. South America, Middle East and Africa Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 55. South America, Middle East and Africa Stage 1 Infant Formula Sales by Country (2021-2026) & (t) Table 56. South America, Middle East and Africa Stage 1 Infant Formula Sales by Country (2027-2032) & (t) Table 57. Global Stage 1 Infant Formula Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Stage 1 Infant Formula Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Stage 1 Infant Formula Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Stage 1 Infant Formula Revenue Market Share by Region (2021-2026) Table 61. Global Stage 1 Infant Formula Revenue Market Share by Region (2027-2032) Table 62. Mead Johnson Company Information Table 63. Mead Johnson Business Overview Table 64. Mead Johnson Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Mead Johnson Stage 1 Infant Formula Product Portfolio Table 66. Mead Johnson Recent Development Table 67. Nestle Company Information Table 68. Nestle Business Overview Table 69. Nestle Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Nestle Stage 1 Infant Formula Product Portfolio Table 71. Nestle Recent Development Table 72. Danone Company Information Table 73. Danone Business Overview Table 74. Danone Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Danone Stage 1 Infant Formula Product Portfolio Table 76. Danone Recent Development Table 77. Abbott Company Information Table 78. Abbott Business Overview Table 79. Abbott Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Abbott Stage 1 Infant Formula Product Portfolio Table 81. Abbott Recent Development Table 82. FrieslandCampina Company Information Table 83. FrieslandCampina Business Overview Table 84. FrieslandCampina Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. FrieslandCampina Stage 1 Infant Formula Product Portfolio Table 86. FrieslandCampina Recent Development Table 87. Heinz Company Information Table 88. Heinz Business Overview Table 89. Heinz Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Heinz Stage 1 Infant Formula Product Portfolio Table 91. Heinz Recent Development Table 92. Bellamy Company Information Table 93. Bellamy Business Overview Table 94. Bellamy Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Bellamy Stage 1 Infant Formula Product Portfolio Table 96. Bellamy Recent Development Table 97. Topfer Company Information Table 98. Topfer Business Overview Table 99. Topfer Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Topfer Stage 1 Infant Formula Product Portfolio Table 101. Topfer Recent Development Table 102. HiPP Company Information Table 103. HiPP Business Overview Table 104. HiPP Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. HiPP Stage 1 Infant Formula Product Portfolio Table 106. HiPP Recent Development Table 107. Perrigo Company Information Table 108. Perrigo Business Overview Table 109. Perrigo Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Perrigo Stage 1 Infant Formula Product Portfolio Table 111. Perrigo Recent Development Table 112. Arla Company Information Table 113. Arla Business Overview Table 114. Arla Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Arla Stage 1 Infant Formula Product Portfolio Table 116. Arla Recent Development Table 117. Holle Company Information Table 118. Holle Business Overview Table 119. Holle Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Holle Stage 1 Infant Formula Product Portfolio Table 121. Holle Recent Development Table 122. Meiji Company Information Table 123. Meiji Business Overview Table 124. Meiji Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Meiji Stage 1 Infant Formula Product Portfolio Table 126. Meiji Recent Development Table 127. Biostime Company Information Table 128. Biostime Business Overview Table 129. Biostime Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Biostime Stage 1 Infant Formula Product Portfolio Table 131. Biostime Recent Development Table 132. China Feihe Company Information Table 133. China Feihe Business Overview Table 134. China Feihe Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. China Feihe Stage 1 Infant Formula Product Portfolio Table 136. China Feihe Recent Development Table 137. Junlebao Dairy Company Information Table 138. Junlebao Dairy Business Overview Table 139. Junlebao Dairy Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Junlebao Dairy Stage 1 Infant Formula Product Portfolio Table 141. Junlebao Dairy Recent Development Table 142. Ausnutria Dairy Company Information Table 143. Ausnutria Dairy Business Overview Table 144. Ausnutria Dairy Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Ausnutria Dairy Stage 1 Infant Formula Product Portfolio Table 146. Ausnutria Dairy Recent Development Table 147. Yili Group Company Information Table 148. Yili Group Business Overview Table 149. Yili Group Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Yili Group Stage 1 Infant Formula Product Portfolio Table 151. Yili Group Recent Development Table 152. Synutra Company Information Table 153. Synutra Business Overview Table 154. Synutra Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Synutra Stage 1 Infant Formula Product Portfolio Table 156. Synutra Recent Development Table 157. Beingmate Company Information Table 158. Beingmate Business Overview Table 159. Beingmate Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Beingmate Stage 1 Infant Formula Product Portfolio Table 161. Beingmate Recent Development Table 162. Yashili Company Information Table 163. Yashili Business Overview Table 164. Yashili Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Yashili Stage 1 Infant Formula Product Portfolio Table 166. Yashili Recent Development Table 167. Bright Dairy Company Information Table 168. Bright Dairy Business Overview Table 169. Bright Dairy Stage 1 Infant Formula Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Bright Dairy Stage 1 Infant Formula Product Portfolio Table 171. Bright Dairy Recent Development Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Stage 1 Infant Formula Distributors List Table 175. Stage 1 Infant Formula Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Stage 1 Infant Formula Product Image Figure 2. Global Stage 1 Infant Formula Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stage 1 Infant Formula Market Size (2021-2032) & (US$ Million) Figure 4. Global Stage 1 Infant Formula Sales (2021-2032) & (t) Figure 5. Global Stage 1 Infant Formula Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Stage 1 Infant Formula Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Conventional Image Figure 9. Organic Image Figure 10. Global Stage 1 Infant Formula Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 11. Global Stage 1 Infant Formula Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Stage 1 Infant Formula Sales Market Share by Type (2021-2032) Figure 13. Global Stage 1 Infant Formula Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Stage 1 Infant Formula Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Stage 1 Infant Formula Revenue Market Share by Type (2021-2032) Figure 16. Online Sales Image Figure 17. Offline Sales Image Figure 18. Global Stage 1 Infant Formula Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 19. Global Stage 1 Infant Formula Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Stage 1 Infant Formula Sales Market Share by Application (2021-2032) Figure 21. Global Stage 1 Infant Formula Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Stage 1 Infant Formula Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Stage 1 Infant Formula Revenue Market Share by Application (2021-2032) Figure 24. North America Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 25. North America Stage 1 Infant Formula Sales Market Share by Country (2021-2032) Figure 26. U.S. Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 27. Canada Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 28. Mexico Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 29. Europe Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 30. Europe Stage 1 Infant Formula Sales Market Share by Country (2021-2032) Figure 31. Germany Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 32. France Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 33. U.K. Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 34. Italy Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 35. Netherlands Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 36. Asia Pacific Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 37. Asia Pacific Stage 1 Infant Formula Sales Market Share by Country (2021-2032) Figure 38. China Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 39. Japan Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 40. South Korea Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 41. Southeast Asia Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 42. India Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 43. Australia Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 44. South America, Middle East and Africa Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 45. South America, Middle East and Africa Stage 1 Infant Formula Sales Market Share by Country (2021-2032) Figure 46. Brazil Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 47. South Africa Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 48. Saudi Arabia Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 49. Turkey Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 50. Argentina Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 51. UAE Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 52. Egypt Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 53. Chile Stage 1 Infant Formula Sales and Growth Rate (2021-2032) & (t) Figure 54. Global Stage 1 Infant Formula Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Stage 1 Infant Formula Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Stage 1 Infant Formula Revenue (2021-2032) & (US$ Million) Figure 57. North America Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Stage 1 Infant Formula Revenue (2021-2032) & (US$ Million) Figure 59. Europe Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Stage 1 Infant Formula Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Stage 1 Infant Formula Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Stage 1 Infant Formula Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Stage 1 Infant Formula Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Conventional
  • Organic
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Mead Johnson
  • Nestle
  • Danone
  • Abbott
  • FrieslandCampina
  • Heinz
  • Bellamy
  • Topfer
  • HiPP
  • Perrigo
  • Arla
  • Holle
  • Meiji
  • Biostime
  • China Feihe
  • Junlebao Dairy
  • Ausnutria Dairy
  • Yili Group
  • Synutra
  • Beingmate
  • Yashili
  • Bright Dairy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stage 1 Infant Formula Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stage 1 Infant Formula Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Stage 1 Infant Formula Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Stage 1 Infant Formula Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Stage 1 Infant Formula Market Dynamics
  1. 2.1 Stage 1 Infant Formula Industry Trends
  2. 2.2 Stage 1 Infant Formula Industry Drivers
  3. 2.3 Stage 1 Infant Formula Industry Opportunities and Challenges
  4. 2.4 Stage 1 Infant Formula Industry Restraints
3 Stage 1 Infant Formula Market by Manufacturers
  1. 3.1 Global Stage 1 Infant Formula Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Stage 1 Infant Formula Sales by Manufacturers (2021-2026)
  3. 3.3 Global Stage 1 Infant Formula Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Stage 1 Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Stage 1 Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Stage 1 Infant Formula Manufacturers, Product Type & Application
  7. 3.7 Global Stage 1 Infant Formula Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Stage 1 Infant Formula Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Stage 1 Infant Formula Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Stage 1 Infant Formula Tier 1, Tier 2, and Tier 3
4 Stage 1 Infant Formula Market by Type
  1. 4.1 Stage 1 Infant Formula Type Introduction
  2. 4.1.1 Conventional
  3. 4.1.2 Organic
  4. 4.2 Global Stage 1 Infant Formula Sales by Type
  5. 4.2.1 Global Stage 1 Infant Formula Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Stage 1 Infant Formula Sales by Type (2021-2032)
  7. 4.2.3 Global Stage 1 Infant Formula Sales Market Share by Type (2021-2032)
  8. 4.3 Global Stage 1 Infant Formula Revenue by Type
  9. 4.3.1 Global Stage 1 Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Stage 1 Infant Formula Revenue by Type (2021-2032)
  11. 4.3.3 Global Stage 1 Infant Formula Revenue Market Share by Type (2021-2032)
5 Stage 1 Infant Formula Market by Application
  1. 5.1 Stage 1 Infant Formula Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Stage 1 Infant Formula Sales by Application
  5. 5.2.1 Global Stage 1 Infant Formula Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Stage 1 Infant Formula Sales by Application (2021-2032)
  7. 5.2.3 Global Stage 1 Infant Formula Sales Market Share by Application (2021-2032)
  8. 5.3 Global Stage 1 Infant Formula Revenue by Application
  9. 5.3.1 Global Stage 1 Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Stage 1 Infant Formula Revenue by Application (2021-2032)
  11. 5.3.3 Global Stage 1 Infant Formula Revenue Market Share by Application (2021-2032)
6 Global Stage 1 Infant Formula Sales by Region
  1. 6.1 Global Stage 1 Infant Formula Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stage 1 Infant Formula Sales by Region (2021-2032)
  3. 6.2.1 Global Stage 1 Infant Formula Sales by Region (2021-2026)
  4. 6.2.2 Global Stage 1 Infant Formula Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Stage 1 Infant Formula Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Stage 1 Infant Formula Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Stage 1 Infant Formula Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Stage 1 Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Stage 1 Infant Formula Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Stage 1 Infant Formula Revenue by Region
  1. 7.1 Global Stage 1 Infant Formula Revenue by Region
  2. 7.1.1 Global Stage 1 Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Stage 1 Infant Formula Revenue by Region (2021-2026)
  4. 7.1.3 Global Stage 1 Infant Formula Revenue by Region (2027-2032)
  5. 7.1.4 Global Stage 1 Infant Formula Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Stage 1 Infant Formula Revenue (2021-2032)
  8. 7.2.2 North America Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Stage 1 Infant Formula Revenue (2021-2032)
  11. 7.3.2 Europe Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Stage 1 Infant Formula Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Stage 1 Infant Formula Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Stage 1 Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Mead Johnson
  2. 8.1.1 Mead Johnson Company Information
  3. 8.1.2 Mead Johnson Business Overview
  4. 8.1.3 Mead Johnson Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mead Johnson Stage 1 Infant Formula Product Portfolio
  6. 8.1.5 Mead Johnson Recent Developments
  7. 8.2 Nestle
  8. 8.2.1 Nestle Company Information
  9. 8.2.2 Nestle Business Overview
  10. 8.2.3 Nestle Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nestle Stage 1 Infant Formula Product Portfolio
  12. 8.2.5 Nestle Recent Developments
  13. 8.3 Danone
  14. 8.3.1 Danone Company Information
  15. 8.3.2 Danone Business Overview
  16. 8.3.3 Danone Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Danone Stage 1 Infant Formula Product Portfolio
  18. 8.3.5 Danone Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Stage 1 Infant Formula Product Portfolio
  24. 8.4.5 Abbott Recent Developments
  25. 8.5 FrieslandCampina
  26. 8.5.1 FrieslandCampina Company Information
  27. 8.5.2 FrieslandCampina Business Overview
  28. 8.5.3 FrieslandCampina Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FrieslandCampina Stage 1 Infant Formula Product Portfolio
  30. 8.5.5 FrieslandCampina Recent Developments
  31. 8.6 Heinz
  32. 8.6.1 Heinz Company Information
  33. 8.6.2 Heinz Business Overview
  34. 8.6.3 Heinz Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Heinz Stage 1 Infant Formula Product Portfolio
  36. 8.6.5 Heinz Recent Developments
  37. 8.7 Bellamy
  38. 8.7.1 Bellamy Company Information
  39. 8.7.2 Bellamy Business Overview
  40. 8.7.3 Bellamy Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bellamy Stage 1 Infant Formula Product Portfolio
  42. 8.7.5 Bellamy Recent Developments
  43. 8.8 Topfer
  44. 8.8.1 Topfer Company Information
  45. 8.8.2 Topfer Business Overview
  46. 8.8.3 Topfer Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Topfer Stage 1 Infant Formula Product Portfolio
  48. 8.8.5 Topfer Recent Developments
  49. 8.9 HiPP
  50. 8.9.1 HiPP Company Information
  51. 8.9.2 HiPP Business Overview
  52. 8.9.3 HiPP Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HiPP Stage 1 Infant Formula Product Portfolio
  54. 8.9.5 HiPP Recent Developments
  55. 8.10 Perrigo
  56. 8.10.1 Perrigo Company Information
  57. 8.10.2 Perrigo Business Overview
  58. 8.10.3 Perrigo Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Perrigo Stage 1 Infant Formula Product Portfolio
  60. 8.10.5 Perrigo Recent Developments
  61. 8.11 Arla
  62. 8.11.1 Arla Company Information
  63. 8.11.2 Arla Business Overview
  64. 8.11.3 Arla Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Arla Stage 1 Infant Formula Product Portfolio
  66. 8.11.5 Arla Recent Developments
  67. 8.12 Holle
  68. 8.12.1 Holle Company Information
  69. 8.12.2 Holle Business Overview
  70. 8.12.3 Holle Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Holle Stage 1 Infant Formula Product Portfolio
  72. 8.12.5 Holle Recent Developments
  73. 8.13 Meiji
  74. 8.13.1 Meiji Company Information
  75. 8.13.2 Meiji Business Overview
  76. 8.13.3 Meiji Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Meiji Stage 1 Infant Formula Product Portfolio
  78. 8.13.5 Meiji Recent Developments
  79. 8.14 Biostime
  80. 8.14.1 Biostime Company Information
  81. 8.14.2 Biostime Business Overview
  82. 8.14.3 Biostime Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biostime Stage 1 Infant Formula Product Portfolio
  84. 8.14.5 Biostime Recent Developments
  85. 8.15 China Feihe
  86. 8.15.1 China Feihe Company Information
  87. 8.15.2 China Feihe Business Overview
  88. 8.15.3 China Feihe Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 China Feihe Stage 1 Infant Formula Product Portfolio
  90. 8.15.5 China Feihe Recent Developments
  91. 8.16 Junlebao Dairy
  92. 8.16.1 Junlebao Dairy Company Information
  93. 8.16.2 Junlebao Dairy Business Overview
  94. 8.16.3 Junlebao Dairy Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Junlebao Dairy Stage 1 Infant Formula Product Portfolio
  96. 8.16.5 Junlebao Dairy Recent Developments
  97. 8.17 Ausnutria Dairy
  98. 8.17.1 Ausnutria Dairy Company Information
  99. 8.17.2 Ausnutria Dairy Business Overview
  100. 8.17.3 Ausnutria Dairy Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ausnutria Dairy Stage 1 Infant Formula Product Portfolio
  102. 8.17.5 Ausnutria Dairy Recent Developments
  103. 8.18 Yili Group
  104. 8.18.1 Yili Group Company Information
  105. 8.18.2 Yili Group Business Overview
  106. 8.18.3 Yili Group Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Yili Group Stage 1 Infant Formula Product Portfolio
  108. 8.18.5 Yili Group Recent Developments
  109. 8.19 Synutra
  110. 8.19.1 Synutra Company Information
  111. 8.19.2 Synutra Business Overview
  112. 8.19.3 Synutra Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Synutra Stage 1 Infant Formula Product Portfolio
  114. 8.19.5 Synutra Recent Developments
  115. 8.20 Beingmate
  116. 8.20.1 Beingmate Company Information
  117. 8.20.2 Beingmate Business Overview
  118. 8.20.3 Beingmate Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beingmate Stage 1 Infant Formula Product Portfolio
  120. 8.20.5 Beingmate Recent Developments
  121. 8.21 Yashili
  122. 8.21.1 Yashili Company Information
  123. 8.21.2 Yashili Business Overview
  124. 8.21.3 Yashili Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Yashili Stage 1 Infant Formula Product Portfolio
  126. 8.21.5 Yashili Recent Developments
  127. 8.22 Bright Dairy
  128. 8.22.1 Bright Dairy Company Information
  129. 8.22.2 Bright Dairy Business Overview
  130. 8.22.3 Bright Dairy Stage 1 Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Bright Dairy Stage 1 Infant Formula Product Portfolio
  132. 8.22.5 Bright Dairy Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Stage 1 Infant Formula Value Chain Analysis
  2. 9.1.1 Stage 1 Infant Formula Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Stage 1 Infant Formula Production Mode & Process
  6. 9.2 Stage 1 Infant Formula Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Stage 1 Infant Formula Distributors
  9. 9.2.3 Stage 1 Infant Formula Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst